Webinar – on demand
Speakers: Prof Hagan Bayley & Dr Mark Kotter
Monday June 29
4pm GMT | 8am PST | 11am EST
A scalable technology platform capable of producing consistent batches of every human cell has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.
3D-printed human neural cells, Hagan Bayley
Precise reprogramming of cells for robust and scalable human cell models, Mark Kotter
You will learn
Today’s challenges in CNS research, disease modelling and drug discovery: limited access to reliable human models
How a novel cellular reprogramming technology, opti-ox, resolves the inconsistency of cellular reprogramming and enables the precise, consistent, and scalable production of human cells
The fabrication of synthetic, printed and hybrid materials, and their applications
Meet our speakers
Hagan Bayley | University of Oxford
Hagan is the Professor of Chemical Biology at the University of Oxford. A major interest of his laboratory is the development of engineered protein nanopores for stochastic detection. In 2005, Professor Bayley founded Oxford Nanopore, which has manufactured the MinION portable DNA sequencer. Recently, the Bayley lab has developed techniques for the fabrication of 3D tissues, both living and synthetic. Professor Bayley is currently a co-Director of the Oxford Martin School programme on 3D Printing for Brain Repair.
Mark Kotter | Founder & CEO Bit Bio
Mark is a stem cell biologist and neurosurgeon at the University of Cambridge. By combining synthetic and stem cell biology, his team has developed a benchmark technology for the efficient and consistent production of human cells for use in research, drug development, and cell therapy. He is the founder of Bit Bio and co-founder of the cultured meat startup Meatable.